98%
921
2 minutes
20
There is a growing amount of evidence that alteration in pain processing by the peripheral and central nervous system play a role in osteoarthritis pain, leading to neuropathic-like symptoms. It is essential to identify knee and hip osteoarthritis patients with a neuropathic pain profile in order to offer such patients education and additional treatment options besides conventional pain treatment. The painDETECT Questionnaire is a self-report questionnaire developed to discriminate between nociceptive and neuropathic pain. This questionnaire was modified to fit patients suffering from knee osteoarthritis. The aim of this study was to translate and cross-culturally adapt the modified painDETECT Questionnaire to the Dutch language and to provide a modified version to fit patients with hip osteoarthritis. Reliability for internal consistency, repeatability and floor and ceiling effects were subsequently assessed. A total of 278 patients were included in the reliability study and 123 patients in the repeatability analysis. The Dutch modified painDETECT Questionnaire shows good internal consistency and small relative measurement errors, represented by a good intraclass correlation coefficient. Absolute measurement error, represented by the Standard Error of Measurement, was acceptable. However, a measurement bias might be present when it comes to repeatability. To our knowledge, this study is the first to provide a Dutch modified painDETECT Questionnaire to fit hip and knee osteoarthritis patients and to assess internal consistency, reliability and agreement. International guidelines were followed in the translation process and this study has ample sample size with an adequate time interval for repeatability. Based on this study, the Dutch modified painDETECT Questionnaire seems to be fit as a discriminative tool to identify knee and hip osteoarthritis patients with a neuropathic pain profile. Whether it is also suitable as an evaluative tool to record changes over time or after an intervention remains open to further investigation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697818 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0146117 | PLOS |
Front Pain Res (Lausanne)
August 2025
UR4391 (ENT Team), Faculty of Health, Paris Est Créteil University, Créteil, France.
Eur J Neurol
September 2025
Department of Neurology, Odense University Hospital, Odense, Denmark.
Background: Fibromyalgia (FM) is a complex chronic pain disorder characterized by widespread musculoskeletal pain and symptoms suggesting autonomic dysfunction. Small fiber neuropathy (SFN) has been described in a subgroup of patients. We aimed to explore the value of structured symptom assessment to identify patients with SFN or autonomic neuropathy.
View Article and Find Full Text PDFPharmaceuticals (Basel)
July 2025
Department of Rehabilitation, Eleonora Reicher National Institute of Geriatrics, Rheumatology and Rehabilitation, Spartańska 1, 02-637 Warsaw, Poland.
Complex regional pain syndrome (CRPS) is a disabling pain condition, which is distinct from other pain syndromes by the presence of autonomic dysfunction and regional inflammatory changes. To explore the impact of pharmacological treatment strategies, specifically scheduled, on-demand dosing regimens versus lack of medical treatment, on pain-related and functional outcomes in rehabilitation for individuals with CRPS. A total of 32 participants with CRPS were assigned to three treatment groups depending on analgesic treatment during the course of complex rehabilitation.
View Article and Find Full Text PDFJ Clin Ultrasound
August 2025
Department of Algology, Ankara Etlik City Hospital, Ankara, Turkey.
Objectives: To evaluate the efficacy of ultrasound (US)-guided pulsed radiofrequency (PRF) treatment of posterior tibial nerve (PTN) in patients with painful diabetic peripheral neuropathy (PDPN) refractory to pharmacotherapy.
Methods: US-guided PTN-PRF treatment was applied for 240 s at a maximum temperature of 42°C with a pulse width of 20 ms in 55 patients with PDPN. The primary aim of this study was to evaluate the efficacy of US-guided PRF treatment of the PTN on pain scores using a Visual Analog Scale (VAS) in patients with type 2 diabetes mellitus who had pharmacotherapy-resistant PDPN.
Rheumatol Int
August 2025
Department of Rheumatology, Medical University of Lodz, Żeromskiego 113, Lodz, 90-549, Poland.
This study aimed to identify risk factors of nociplastic pain in patients with autoimmune arthritis. Patients suffering from chronic pain and autoimmune arthritis were invited to participate in a study via moderated support groups on social media. Each invitation included a brief description of nociplastic pain.
View Article and Find Full Text PDF